NSE:SUNPHARMA   SUN PHARMACEUTICAL
While the initial risk-reward is not very favorable 430-440 SL with 540 targets. If the 540 levels are sustained 600 could be a direct run.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.